Now let me write the final consolidated review.

## Summary

PLAGUE is a modular, plug-and-play framework for generating multi-turn jailbreak attacks against LLMs. It decomposes attack generation into three phases (Planner, Primer, Finisher) with a lifelong-learning memory bank that stores successful strategies for future retrieval. Evaluated on HarmBench against models including o3, o1, Deepseek-R1, Claude Opus 4.1, and Llama 3.3-70B, PLAGUE achieves 81.4% SRE on o3 and 67.3% on Claude Opus 4.1, with a controlled budget analysis showing these gains are not from brute-force query overhead.

## Strengths

- **Clean modular design with strong ablation support.** The three-phase decomposition (Planner → Primer → Finisher) with lifelong learning is principled, and Tables 3 and 4 demonstrate monotonic improvement as components are added one at a time, cleanly isolating each component's contribution.
- **Strong headline results on the hardest models.** PLAGUE achieves 81.4% SRE on o3 (vs. next-best GOAT at 58.7%) and 67.3% on Claude Opus 4.1 (Table 2, 4), two models considered highly resistant to jailbreaking.
- **Budget-aware efficiency analysis.** Table 5 reports actual Target, Evaluator, and Planner LLM calls, showing PLAGUE achieves its gains within one extra Target call of GOAT and often fewer total calls than Crescendo. This rules out the trivial explanation that higher ASR comes from brute-force query volume.

## Weaknesses

### Major

- **No variance reporting despite three runs.** Line 155 states scores are "averaged over three runs for robustness," yet every table (Tables 2, 3, 4) reports only point estimates — no standard deviations, confidence intervals, or per-run breakdowns. Given that the Attacker LLM, Rubric Scorer, and Target LLM all operate at non-zero temperature, the variance across runs could be substantial. Without any variability measure, the reader cannot assess whether a reported improvement (e.g., 0.814 vs. 0.587 on o3) is reliable or driven by a lucky seed. This is the single most critical evidential gap.

- **Baseline configurations modified in ways that may disadvantage them.** Lines 157–161 disclose: disabling GOAT's attack history, early-stopping GOAT when a rubric score >8/10 is reached, limiting ActorBreaker's K=2, removing Crescendo's backtracking counts, and capping turns at six. The authors assert that "the impact on GOAT's performance with and without an attack history is negligible" but provide no supporting data. Each individual change may be defensible, but the cumulative effect of configuring all baselines by the PLAGUE authors (rather than using their reported best configurations) creates a risk of inadvertent disadvantage. Results using the baselines' default/official configurations should be reported alongside the modified versions.

- **The abstract's "30% across leading models" claim is selectively true.** The abstract (line 11) claims PLAGUE "improving attack success rates (ASR) by more than 30% across leading models." Table 2 tells a different story: Deepseek-R1 shows identical ASR (0.978 for both PLAGUE and GOAT, ~0% improvement), Llama 3.3-70B shows ~0.8% improvement (0.958 vs. 0.950). The 30%+ figure holds for o3 (~39%) and Opus 4.1 (40.2% in Table 4), but not "across leading models" generally. The claim should be qualified to specify which models see substantial gains.

### Minor

- **Diversity is invoked as a motivation and claimed quantitatively, but never defined.** The paper motivates diversity (Section 1: "sample adaptively with diversity") and makes a quantitative claim (line 40: "diversity improves by 15%", referencing Figure 3). However, no diversity metric is defined in the main text. A number without a unit ("15%") is uninterpretable.
- **Duplicate row in Table 2.** ActorBreaker appears twice with identical numbers (lines 174–175). This appears to be a table construction error.

### Trivial

None.

## Nice-to-Haves

- Sensitivity analysis on Rubric Scorer thresholds (currently 7/10 for Primer backtracking, 3/10 for Finisher backtracking, 8/10 for success) would strengthen the paper's methodological foundation.
- Clarify whether all baselines use the same Attacker LLM (Deepseek-R1) as PLAGUE for a fully apples-to-apples comparison.

## Removed Points

These points are flagged to be removed, treat them with caution:

- **"PLAGUE vs. baselines uses PLAGUE's own components as competitors"** — The ablation study (Table 3) already cleanly separates incremental contributions, and Table 2 also compares against methods (Crescendo, ActorBreaker, AutoDAN-Turbo) that are not components of PLAGUE. Comparing a modular framework against its constituent modules is standard practice and not a genuine weakness.
- **"Duplicate row in Table 2"** — Actually kept as a Minor weakness since it's a verifiable error.
- **Various speculative weaknesses about appendix contents** — Removed per rules: missing appendix content is a parser artifact, not an author error.
- **Strengths about "timely and important problem" without specific paper evidence** — Removed per filtering rules for generic strengths. The remaining strengths are all concrete and paper-grounded.

## Novel Insights

The harsh critic's observation that the ablation study (Table 3) is the paper's strongest evidence — stronger than the headline comparison (Table 2) — is insightful. Table 3 shows clean monotonic improvement as each component is added, while Table 2 compares PLAGUE against baselines that are themselves components of PLAGUE (GOAT) or were configured by the authors. Leading with the ablation narrative and using the headline results as supporting evidence would present a more honest and defensible empirical case.

## Suggestions

1. Report standard deviations, confidence intervals, or per-seed results for all tables. The paper already runs three seeds — this information exists and simply needs to be reported.
2. Run baselines in their recommended/official configurations alongside any modified versions, or provide empirical evidence that the modifications do not harm performance.
3. Correct the "30% across leading models" claim to specify which models see substantial gains and report the full range.
4. Define the diversity metric in the main text and report the actual measured values rather than a bare percentage.
5. Fix the duplicate row in Table 2.

## Score and Decision

**Bracket (Round 1):** Based on calibration anchors, this paper sits between the 4–6 range. Papers at 3.0–3.75 (Quack, Multi-round Conversational Jailbreaking) have weaker evaluations and limited baselines; papers at 5.33–6.25 (Derail Yourself, Improved Techniques for Optimization-Based Jailbreaking, Simple Adaptive Attacks) have solid contributions but notable evidential gaps. PLAGUE's method contribution is stronger than the 3–4 range papers, and its evaluation breadth (5 models, 200 HarmBench samples, multiple baselines, ablation, efficiency analysis) is more comprehensive than the 5.33 Derail Yourself paper. However, the evidential issues (no variance, baseline modifications, overclaim) are more significant than those in the 6.14–6.25 accepted papers.

**Calibration Anchors Used:**
- "Derail Yourself" (5.33, Reject) — Similar multi-turn attack paper; less comprehensive evaluation; rejected despite plausible method.
- "Uncovering Model Vulnerabilities With Multi-Turn Red Teaming" (5.75, Reject) — Human red-teaming paper with mixed reviews; evaluated only one model.
- "Jailbreaking Leading Safety-Aligned LLMs with Simple Adaptive Attacks" (6.14, Accept) — Strong empirical results but inconsistent baselines/comparisons; accepted despite similar concerns.
- "Improved Techniques for Optimization-Based Jailbreaking" (6.25, Accept) — Solid incremental contribution; accepted with presentation issues.
- "Curiosity-driven Red-teaming" (8.0, Accept) — Exemplary paper with thorough evaluation and clear presentation; PLAGUE is not at this level.

**Final Score:** The paper's modular framework is a genuine contribution and the evaluation is more comprehensive than many comparable papers. However, the absence of any variance reporting, combined with baseline modifications that may disadvantage competitors and an overstated central claim, collectively prevent acceptance in the current form. The issues are fixable but material.

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Reject</decision>